Lv4
740 积分 2022-08-16 加入
T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy
4天前
求助中
Oncolytic virus VG161 in refractory hepatocellular carcinoma
1个月前
已完结
Recent advances in oncolytic virus therapy for hepatocellular carcinoma
1个月前
已完结
Progress and challenges in glypican-3 targeting for hepatocellular carcinoma therapy
1个月前
已完结
Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis
1个月前
已完结
A novel bispecific antibody as an immunotherapeutic agent in hepatocellular carcinoma
1个月前
已完结
Novel strategies to manage CAR-T cell toxicity
1个月前
已完结
CAR immune cells: design principles, resistance and the next generation
1个月前
已完结
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment
1个月前
已完结
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
1个月前
已完结
皖公网安备34019202002308
